Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-5,443
Closed -$441K 103
2023
Q2
$441K Buy
5,443
+973
+22% +$79.5K 0.03% 69
2023
Q1
$361K Sell
4,470
-1,694
-27% -$136K 0.02% 55
2022
Q4
$462K Hold
6,164
0.03% 40
2022
Q3
$398K Buy
+6,164
New +$427K 0.03% 41
2021
Q4
Sell
-22,063
Closed -$1.63M 126
2021
Q3
$1.63M Sell
22,063
-7,638
-26% -$573K 0.1% 41
2021
Q2
$1.98M Buy
29,701
+10,139
+52% +$678K 0.13% 26
2021
Q1
$1.46M Buy
19,562
+8,810
+82% +$669K 0.1% 82
2020
Q4
$783K Buy
+10,752
New +$759K 0.06% 111

Other funds holding HOLX

SRB Corp's HOLX Position: Q3 2023 in Review

SRB Corp sold out of Hologic (HOLX) in Q3 2023, closing a stake of 5,443 shares — an estimated $441K sold.

SRB Corp first reported a position in HOLX in Q4 2020 and held it in 8 quarters. The position peaked at $1.98M in Q2 2021. 693 funds tracked by Wall St. Rank hold HOLX as of Q3 2023.

  • SRB Corp reported no remaining Hologic position as of Q3 2023 after selling out during the quarter.
  • SRB Corp sold 5,443 Hologic shares in Q3 2023, an estimated $441K.
  • SRB Corp first reported a position in Hologic in Q4 2020 and held it in 8 quarters.
  • SRB Corp's Hologic position peaked at $1.98M in Q2 2021.
  • 693 funds tracked by Wall St. Rank held Hologic as of Q3 2023.

Based on SRB Corp's 13F filing for Q3 2023, filed 14 Nov 2023.